Dietary supplement industry-proposed drug-like GMPs advanced notice moving at FDA.
This article was originally published in The Tan Sheet
Executive Summary
FDA DIETARY SUPPLEMENT GMPs ANPR IN PROCESS of moving toward publication, Office of Special Nutritionals Director Elizabeth Yetley, PhD, suggested at the Food & Drug Law Institute annual educational conference Dec. 11. Yetley said "FDA is in the process of attempting to publish an Advance Notice of Public Rulemaking" concerning the use of drug-like Good Manufacturing Practices requirements for quality control issues relating to dietary supplements.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning